CCS scientists identify new best-in-class protease inhibitor for the treatment of Helicobacter-induced gastric cancer

July 22, 2015

The Wessler lab (CCS, PLUS) contributed to the discovery of the currently best-in-class inhibitor of Helicobacter pylori HtrA. The new inhibitor can be seen as a pioneering tool for chemical biology and potential lead structure for anti-cancer and anti-infective drug discovery. read more...

Please reload

 Recommended News 

Salzburg Breast Cancer Meeting - Mastering Translational Immuno-Oncology

January 13, 2017

Please reload

 Recent News 
Please reload